酶激活的P-类固醇蛋白的立体选择性合成
Shuai-Shuai Fang1, XiangJun Hu2, Ming-Hong Li1,3
1Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, China.
研究人员开发了一种使用奇拉金属复合物的立体选择性合成方法. 这种方法改善了抗病毒和抗癌药物的生产.
科学领域:
- 医学化学
- 有机合成
- 催化剂
背景情况:
- ProTide技术已经导致FDA批准的治疗病毒感染和癌症的药物,如索福斯布维尔和雷梅西维尔.
- 在ProTides中中心的立体化学对于其药理活性至关重要,要求有效的立体选择性合成.
- 现有的合成方法往往是低效的或有限的,这凸显了对新方法的需求.
研究的目的:
- 开发一种新的,高度刻板选择的合成P-类固醇蛋白质的方法.
- 解决ProTide合成的传统和当前有机催化方法的局限性.
- 为了准备以前无法获得的ProTide立体同位素.
主要方法:
- 使用性金属复合物催化不对称的PO键形成.
- 采用基质促进的核替代途径,由性金属催化剂激活.
- 研究了机理方面的反应路径.
主要成果:
- 在温和条件下实现 (S,Rp) 和 (R,Sp) -ProTide衍生物的高度立体选择性合成.
- 证明了开发的协议的广泛适用性.
- 成功准备了与药物相关的ProTide目标,并展示了其实用性.
结论:
- 这种新的合金属复合催化方法为P-类固醇蛋白提供了一种高效和立体选择性途径.
- 这种方法为抗病毒和抗癌药物候选物的合成提供了显著的进步.
- 这些发现有助于改善核类同类药物开发和制药研究.
更多相关视频
06:31Highly Stereoselective Synthesis of 1,6-Ketoesters Mediated by Ionic Liquids: A Three-component Reaction Enabling Rapid Access to a New Class of Low Molecular Weight Gelators
Published on: November 27, 2015
09:14Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine
Published on: February 16, 2018
相关概念视频
Diels–Alder Reaction Forming Cyclic Products: Stereochemistry
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Prochirality
α-Alkylation of Ketones via Enolate Ions
Regioselectivity of Electrophilic Additions to Alkenes: Markovnikov's Rule
The hydrohalogenation of an unsymmetrical alkene can yield two haloalkane products, depending on which vinylic carbon takes up the halogen. However, one product usually predominates, where hydrogen adds to the vinylic carbon bearing the...
